²Ä¤T³¹ ¯×½è
²Ä¤@¸`_¯×½è¤§¯S©Ê
²Ä¤G¸`_¯×½è¤ÀÃþ
²Ä¤T¸`_¯×½è¤§®ø¤Æ¡B§l¦¬»P¥NÁÂ
²Ä¥|¸`_¯×½èªº»Ýn¶q
²Ä¤¸`_¯×½è»P¤ß¦åºÞ¯e¯f¯×½è¤§¯Ê¥F¯g
¤pÀɮסGOmega-3¯×ªÕ»Ä
°Ñ¦Ò¤åÄm
¤pÀɮסGOmega-3¯×ªÕ»Ä¡B¤¤Ãì¯×ªÕ»Ä¡]MCT¡^
¯×½è¡]Lipid¡^¡G¥]¬A¡G¯×ªÕ¡]Fats¡^»Pªo¯×¡]Oil¡^¡C¥ÑºÒ¡B²B¤Î®ñ©Ò²Õ¦¨¡A¤£·»©ó¤ô¡A¥i·»©ó¦³¾÷·»¾¯¦p¤Aîũδâ¥é¡A¼sªxªº¦s¦b©ó¥Í©RÅ餤¡A¦p¡G´Óª«ªo¡B¥¤ªo¡B½Þªo¡B¤ûªo»Pþµ¥¯×½è¡C¬°¨Å餧¥Dn¦¨¤À¡A¬°¨Ñµ¹¯à¶q¡A¥Ö¤U¯×ªÕ¬°¹j¼ö¡A¨¾¤î¼ö¯à´²¥¢¡A«OÅ@¾¹©x¡A«OÅ@¯«¸g¶Ç¾É¥¿±`¡A¯×½è¦³µ´½t¤§§@¥Î¡A«P¶i²ÓMªº¥NÁ¡A¨Ñµ¹¥²»Ý¯×ªÕ»Ä¡A¦³¼W¥[¹¡¹·P»P¼í·ÆÁT«K¤§¥\¯à¡C
²Ä¤@¸` ¯×½è¤§¯S©Ê
[top]
¤@¡B ªo¯×ªº¥\¯à
1.
´£¨Ñ¯à¶q¡G¯×ªÕ»Ä´£¨Ñ¤F60%¤HÅé©Ò»Ý¼ö¶q¡A¦Ù¦×©Ò»Ýnªº¯à¶q¥Dn¨Ó¦Û¶¼¹Äá¨úªºªo¯×»PÁÞÃþ©M¯×ªÕ²Õ´Àx¦sªº¯×ªÕ»Ä¡C¦b°¨©ÔªQ©Î¦Û¥Ñ¨®µ¥@¤O¹B°Ê¤¤¡A°£¤F¯×ªÕ»Ä¤§¿U¿N´£¨Ñ¦Ù¦×¨Ï¥Î¥~¡A¤]¦³¤j¶qªºÁÞÃþ°Ñ»P¡C¤HÅé²Õ´»Ýn¯×ªÕ»Ä¨Ó´£¨Ñ¼ö¶q¡C¦]¦¹¡Aªo¯×»PÁÞÃþ¤@¼Ë§¡¯à´£¨Ñ¯à¶q¡A³£¦³«OÅ@Å餺³J¥Õ½èªº®ÄÀ³¡A¥iÁ×§KÅé²Õ´ªº¯Ó·l¡C¤T¥Ìªoà¡}Triglycerides¡~¨C¤½§J¥i¥H²£¥Í9¤j¥d¼ö¶q¡A¤ñ³J¥Õ½è©ÎÁÞÃþ¥u¯à²£¥Í4¤j¥d¡Aªo¯×´£¨Ñ¯à¶qªº®Ä²v°ª«Ü¦h¡C
2. Àx¦s¼ö¶q¡G¤HÅé¥H¯×ªÕªº§Î¦¡Àx¦s¯à¶q¡AÀx¦sªo¯×ªº²ÓMºÙ¬°¯×ªÕ²ÓM¡}Adipocytes¡~¡A¤j¶qªº¯×ªÕ²ÓM§Î¦¨¯×ªÕ²Õ´¡}Adipose
tissue¡~¡C¦p¤k©Ê¯Ý³¡»PÁv³¡¯×ªÕ¸û¦h¡A¥i¥H¨ÑÃh¥¥©M÷¨Å´Áªº§Q¥Î¡C¦pªG¼ö¶qÀx¦s¦b¦Ù¦×²Õ´¤¤¡A«h·|¤@¨ÖÀx¦s³\¦h¤ô¥÷¡Aª½±µ¥H¯×ªÕ¥u»Ý¸û¤Ö¯à¶q´N¯àÀx¦s¡C
3.
¹jµ´»P«OÅ@§@¥Î¡G¯×ªÕ²Õ´ªº«¶q¤j¬ù¦ûÅ髪º15-30%¡C¤ºÅ¦¯×ªÕ¦s¦b«nªº¤ºÅ¦¾¹©x¡]¨Ò¦pµÇŦ¡^¥~¼h¡A¯à¨¾¾_©M´î¤Ö¾¹©x¶Ë®`¡C¤k©Êªº¯Ý³¡»PÁv³¡¯×ªÕ¸û¦h¡A¦³«OÅ@¥Í´Þ¾¹©xªº¥\¥Î¡C¥Ö¤U¯×ªÕ²Õ´¦s¦b¥Ö½§¯u¥Ö©³¤U¡A¥i¥H¹jµ´©M«OÅ@¾¹©x§K©ó¨ü¶Ë¡C¯×ªÕ²Õ´ªº¹jµ´¡B«OÅ@»PŨ¹Ôªº¥\¯à¡A¥i¥H´î¤Ö¬¡°Ê®Éªº¯kµh¤Î¥Ö½§¹ï§C·Åªº½Õ¾A±Ó·P¡C¦p´H±a°Êª«¹³¥_·¥ºµ¡B®ü°\©MÄH³½³£¦³¤j¶q¯×ªÕ²Õ´¡A¥H¹jµ´´H§NªºÀô¹Ò¡C
4.
¹B°e¯×·»©Êºû¥Í¯À¡G¯×ªÕ¯àÄâ±a¹ª«¤¤ªºªo·»©Êºû¥Í¯À¡]A¡AD¡AE©MK¡^¶i¤J¤p¸z¡A¥H§Q§l¦¬¡C·í¸z¹D¥Í¯f®É¡A«hµLªk®ø¤Æ§l¦¬¯×ªÕ¡A¯×·»©Êºû¥Í¯À´N·|©M¯×ªÕ¶i¤J¤j¸z¡A©MÁT«K¤@°_±Æ¥XÅé¥~¡C¯×ªÕ§l¦¬¤£¨}ªº¤H¡A¥i¯à·|¯Ê¥F¯×·»©Êºû¥Í¯À¡]¤×¨ä¬OK¡^¡C¦]¦¹¡A´î¤Ö¹«~¤¤ªºªo¯×§t¶q¡A¦P®É¤]´î¤Ö¯×·»©Êºû¥Í¯Àªº§t¶q¡A¦p¡G§C¯×¥¤¡B²æ¯×¥¤µ¥¡C
5. ´£¨Ñ¥²»Ý¯×ªÕ»Ä¡G¨Èªo»Ä¡]Linoleic
acid¡^»Pn-3¨t¦C¯×ªÕ»Ä¡A¥Î©ó¦X¦¨¤G¤QºÒ²m»Ä±Ú¦¨¤Àµ¥²£ª«¡A»P²üº¸»XÃþ¦ü¨ã¦³½Õ¸`¥Í²zªº§@¥Î¡C·í¯Ê¥F¥²»Ý¯×ªÕ»Ä·|¨Ï¥Ö½§µ²ºc¨ü¶Ë¡A®e©ö¥¢¥h¤ô¤À¦Ó°®Àê¡C
6.
ºc³y»P½Õ¸`§@¥Î¡GÁC¯×½è©MÁx©T¾J¦b¤HÅ餺¦³«nªº¥Í²z¥\¯à¡CÁC¯×½è¬Oºc¦¨²ÓM½¤¤§¦¨¥÷¡A¤]¬O¦å²G¤¤¯×³J¥Õªº«n¦¨¤À¡A¨ó§U¯×ªÕªº¹B°e¡C¦b¹ª«¤¤¡AÁC¯×½è¥i¥H§@¬°¨Å¤Æ¾¯¡A«P¶i¤ô¤À»Pªo¯×ªº¤¬·»©M¦w©w©Ê¡CÁx©T¾J¤]¬O²ÓM½¤ªº¦¨¤À¡A¸£³¡§t¶q«Ü¦h¡A¥À¥¤¤¤ªº§t¶q°ª¡A¹ï©ó¥Íªø»Pµo¨|¤]¬O«Ü«n¡CÁx©T¾J©óÅ餺¯à¦X¦¨ÁxÆQ¡Bºû¥Í¯À¢Ò»P©T¾JÃþ¿E¯Àµ¥¡C
7.
´£¨Ñ¹¡¨¬·P¡G¯×½è¨Ï¹ª«¦bG°±¯d±o¤ñ¸û¤[¡A´£¨Ñ¤F¹¡¨¬·P¡C¦pªG¹ª«¤j³¡¥÷¬OÁÞÃþ©Î³J¥Õ½è¡A°±¯d¦bGªº®É¶¡´N¤ñ¸ûµu¡C¤Ö¦Yªo¯×¡A´N·|¥¢¥h¹¡¨¬·P¦Ó«Ü®e©ö´N¾j¤F¡C
8.
´£¨Ñ¹ª«·¨ý©M½è·P¡GµuÃ쪺¯×ªÕ»Ä¯àµo´§¥XªÚ»»®ð¡A¦³³\¦h»®Æ¬O¯×·»©Êªº¡A¦Ó¥Bªo¯×¥i¥H¥[¼ö¨ì200¢J¡Aªo·Î©Îªo¬µ¨Ï¹ª«§Ö³t¥[¼ö¡AÁYµu²i½Õªº®É¶¡¦Ó«O¯d§ó¦hªº·¨ý¡A©ñ¦bªo¸Ìªº½Õ¨ý®Æ¥i¯à·|´²µo¥X¿@§ªº»¨ý¡C¦U¦¡ªº¬ü¨ý¨ÎÀa¡A³£¦³°ªªoªº¯S©Ê¡A³oºØªo¯×ªº·¨ý¬O¤HÃþ¦@¦P³ß¦nªº¯S©Ê¡C
¤G¡B ªo¯×¤§¤Æ¾Ç²Õ¦¨ ¡G
ªo¯×ªººc³y³æ¦ì¡G¯×ªÕ»Äªº°ò¥»ºc³y¡G¥Dn¬OºÒ¡A²B¡A®ñ¤¸¯Àºc¦¨¡C¤À¤lªº°©¬[¬O¥ÑºÒì¤l¦ê³s¦Ó¦¨¡AºÒ¤¸¯À¥HC¥Nªí¡A¤@ºÝ¬°¥Ò°ò¡]CH3-¡^¡A¥t¤@ºÝ¬°»Ä¡]-COOH¡^¡AºÒì¤l¤§¶¡¥H¦@»ùÁä¦êÁp¡A¤¤¶¡ªººÒì¤l¤W³£³s±µ¦³¨âÓ²Bì¤l¡C¥Ò°òºÝ¤]ºÙ¬°
n ºÝ©Î £s ºÝ¡A»Ä°òºÝ¤SºÙ¬° £\
ºÝ¡C¶¼¹¤¤¤§ªo¯×¥H¤T»Ä¥Ìªoର¥D¡A¦û95¢M¥H¤W¡C°ò¥»¤Æ¾Çµ²ºc¬O¤@¤À¤l¥Ìªo¡]Glycerol¡^»P¤T¤À¤l¯×ªÕ»Ä(Fatty
acids)¤Æ¦X¡Cªo¯×ªº¯S©Ê¨ú¨M©ó©Ò§tªº¯×ªÕ»Ä¡A¦]¬°¦UºØªo¯×³£§t¦³¥Ìªo¡C
1. ²³æ¯×½è¡G¥Ìªo»P¯×ªÕ»Äºc¦¨ªºªo¯×¡C¦p¡G¤T»Ä¥Ìªo¯×§t¦³¤@¤À¤l¥Ìªo»P¤TӯתջĤÀ¤l¡C
¹Ï3-1. ¤T»Ä¥Ìªo¯×»P¯×ªÕ»Äºc¦¨ªºªo¯×
2. ½Æ¯×Ãþ¡G§t¥Ìªo¡B¯×ªÕ»Ä¡BÁC»Ä®Ú»PÆQ°ò¡C
¦p¡GÁC¯×½è§t¦³¤@¤À¤l¥Ìªo¡B¨â¤À¤l¯×ªÕ»Ä¡B¤@¤À¤lÁC»Ä®Ú¡B¤@¤À¤lÁxÆP¡C
¹Ï3-2. ½Æ¯×Ãþ¡G§t¥Ìªo¡B¯×ªÕ»Ä¡BÁC»Ä®Ú»PÆQ°ò
3.
l¯×Ãþ¡G¤£§t¥Ìªoªº¯×½è¡A¨Ò¦pÁx©T¾J¡C¤HÅ餧¯×½è¤S¤À¬°¤º¥Í©Ê¡]¬°Å餺¤º³¡²Õ´¤§¤@¡^¤Î¥~¥Í©Ê¡]¥Ñ¹ª«¤¤¤§°Êª«ªo¯×»P´Óª«ªo¡^¡C¥Dn¬°¤T»Ä¥Ìªoà§Y¤@¤À¤l¤§¥Ìªo¤Î¤T¤À¤l¤§¯×ªÕ»Ä¡C
¹Ï3-3. ¤£§t¥Ìªoªº¯×½è¡A¦pÁx©T¾J
¤T¡B¯×ªÕ»Äªº¤Æ¾Ç§@¥Î¡G
²B¤Æ§@¥Î¡]Hydrogenation¡^¡G¤£¹¡©M¯×ªÕ»Ä»P²Bªº¤Æ¾Ç§@¥Î¡A¨Ï±o¤£¹¡©MªºÂùÁä¡}C=C¡~Åܬ°¹¡©Mªº³æÁä¡}C¢wC¡~¡A¥i¨Ï¯×½è§ó¥[éw¡A¦p²B¤Æªo¡C
®ñ¤Æ§@¥Î¡]Oxidation¡^¡G¤£¹¡©M¯×ªÕ»Ä»P®ñªº¤Æ¾Ç§@¥Î¡A¨Ï±o¤£¹¡©MªºÂùÁä¡}C=C¡~Åܬ°»Ä©Î§Î¦¨¹L®ñ¤Æ²{¶H¡A¥i¨Ï¯×½è«~½è°§C¡A²£¥Íªo¯Ó¨ý©Î¹L®ñ¤Æª«¡C¦³¨Ç«h²£¥Íà¬Åé¡]Ketone
bodies¡^¡A¦p²£¥Í¡G¤þଡ]Acetoacetic acid¡BAcetone¡B£]-hydroxybutyric acid¡^
¨m¤Æ§@¥Î¡]Saponification¡^¡G¯×ªÕ»Ä»PÆP©Êª«½èªº¤Æ¾Ç§@¥Î¡A²£¥Í¨m¤Æ§@¥Î¡A±`¥Î©óªÎ¨m¤§¥[¤u¡C
»Ä±Ñ§@¥Î¡GÂùÁä¦ì¸mªººÒ®e©ö»P®ñ¶i¦æ®ñ¤Æ§@¥Î¡A°ª·Å¹¤ÏÀ³§ó§Ö¡A¤Þµo¤@³s¦êªº¤À¸Ñ©Î»E¦X¤ÏÀ³¡A²£ª«¦³¤£¨}ªºÃC¦â©M®ð¨ý¡A³y¦¨ªo¯×®ñ¤Æ»Ä±Ñ¡A²£¥Í¹L®ñ¤Æª«¡A¨Ï±oªo¯×ªº«~½è°§C¡C
¡@
²Ä¤G¸` ¯×½è¤ÀÃþ
[top]
1. ºÒ¼Æ©ÎºÒÃìªø«×¡G¯×ªÕ»Ä¤À¤lªºªø«×¤ÑµMªº¯×ªÕ»Ä¤À¤l©Ò§tªººÒì¤lӼƳq±`¬°°¸¼Æ¡A¥HCnªí¥Ü¡AC¥NªíºÒì¤l¡An¥NªíºÒì¤lªº¼Æ¥Ø¡C¯×ªÕ»Ä¨ÌºÒ¼Æ¥i¤À¬°µuÃì¡]ºÒ¼Æ4-6Ó¡^¡B¤¤Ãì¡]ºÒ¼Æ8-12Ó¡^»PªøÃì¡]ºÒ¼Æ¤j©ó©Îµ¥©ó14Ó¡^¯×ªÕ»Ä¤TÃþ¡CºÒÃì¶Vªø¡A«Ç·Å¤U¶V®e©ö¾®©T¦Ó§Î¦¨©TºA¡C
2. ÂùÁ伯¥Ø©Î¹¡©M«×¡G¯×½è¥i¤À¬°¤£¹¡©M¯×ªÕ»Ä¤Î¹¡©M¯×ªÕ»Ä¡A¯×ªÕ»ÄªººÒì¤l¤§¶¡¦pªG¥þ³¡¥H³æÁä¡}C¢wC¡~µ²¦X¡A´NºÙ¬°¹¡©M¯×ªÕ»Ä¡]Saturated
fatty acid, SFA¡^±`¨£ªº¦³µw¯×»Ä¡]Stearic
Acid¡^¬°18ÓºÒªº¹¡©M¯×ªÕ»Ä¡B´ÄÃq»Ä¡]16ÓºÒªº¹¡©M¯×ªÕ»Ä¡^¡Bªo»Ä¡]16ÓºÒªº¤£¹¡©M¯×ªÕ»Ä¡^µ¥¡C¦p¦³ÂùÁä¡}C=C¡~¡A´NºÙ¬°¤£¹¡©M¯×ªÕ»Ä¡]Unsaturated
fatty acid, UFA¡^¡C¯×ªÕ»Ä¤§ÂùÁ伯¥Ø¥i¥H²Å¸¹Cn:xªí¥Ü¡An¬°ºÒì¤lӼơAx¬°ÂùÁäӼơC¤£¹¡©M¯×ªÕ»Ä¥i¥H¨ÌÂùÁäӼƤÀ¬°³æ¤¸¤£¹¡©M¯×ªÕ»Ä¡]Monounsaturated
fatty acid, MUFA¡^»P¦h¤¸¤£¹¡©M¯×ªÕ»Ä¡]Polyunsaturated fatty acid, PUFA¡^¨âÃþ¡C
³æ¤¸¤£¹¡©M¯×ªÕ»Ä§t¦³¤@ÓÂùÁ䪺¤£¹¡©M¯×ªÕ»Ä¡A¦pªo»Ä¡A©óªá¥Íªo¡B¾ñÆVªo¤¤¡C¦h¤¸¤£¹¡©M¯×ªÕ»Ä§t¦³¨âÓ©Î¥H¤WªºÂùÁ䪺¤£¹¡©M¯×ªÕ»Ä¡A¦p¨È³Âªo»Ä¡B¦¸¨È³Âªo»Ä¡A©ó´ÄÃqªo¡B½µæªo¤Î³½ªo¤¤¡CÂùÁä·U¦hªí¥Ü¹¡©M«×¶V§C¡A©Î·U¤£¹¡©M¡C·íªo¯×§t¤£¹¡©M¯×ªÕ»Ä¶V¦h¡A«Ç·Å¤U§e²GÅ骬ºA¡A¦Ó§t¹¡©M¯×ªÕ»Ä·U¦h¡A«h©ö¬°©TÅ髬ºA¡CÂùÁä¼vÅT¯×ªÕ»Äªº¦w©w©Ê¡AÂùÁä¦ì¸mªººÒ®e©ö»P®ñ¶i¦æ®ñ¤Æ§@¥Î¡A°ª·Å¹¤ÏÀ³§ó§Ö¡A¤Þµo¤@³s¦êªº¤À¸Ñ©Î»E¦X¤ÏÀ³¡A²£ª«¦³¤£¨}ªºÃC¦â©M®ð¨ý¡A³y¦¨ªo¯×®ñ¤Æ»Ä±Ñ¡A²£¥Í¹L®ñ¤Æª«¡A¨Ï±oªo¯×ªº«~½è°§C¡C³q±`¤£¹¡©Mªo¯×ÂùÁä¶V¦h¡A¦w©w©Ê¶V®t¡C
¤£¹¡©Mªo¯×ªºÂùÁäÂǥѲB¤Æ§Þ³N¥i¥HÂà¤Æ¦¨³æÁä¡A¦]¦Ó´£ª@ªo¯×ªº¦w©w©Ê¡C²B¤Æ§Þ³N¤]¥Î¨Ó»s³y´Óª«©Ê¥¤ªo¡A²GºAªº´Óª«ªo¸g¹L²B¤Æ«á¹¡©M«×¤É°ª¡AÅܦ¨Ãþ¦ü¥¤ªoªº©TÅé¡A¼W¥[éw©ÊÀ³§ó¾A¦X¯MµHªº¥Î³~¡C
3. ÂùÁ䪺´X¦ó«¬ºA¡G¤£¹¡©M¯×ªÕ»ÄÁÙ¥i¥H¨ÌÂùÁ䪺´X¦ó«¬ºA¤À¬°¶¶¦¡¡]Cis- form¡^»P¤Ï¦¡¡]Trans-
form¡^¨â«¬¡CÂùÁ䪺ºÒì¤l¤W©Ò³sµ²ªº²Bì¤l¡AY¦bÂùÁä¦P¤@°¼«h¬°¶¶¦¡¡AY¦b¤£¦P°¼¡A«h¬°¤Ï¦¡¡C¤ÑµMªo¯×¤¤ªº¤£¹¡©M¯×ªÕ»Ä¤j¦h¬°¶¶¦¡«¬ºA¡A¥u¦³¤û¨Å»P²B¤Æªo¯×§t¦³¤Ö¶q¤Ï¦¡¯×ªÕ»Ä¡A¥[¤uªo¯×¸û©ö²£¥Í¤Ï¦¡¯×ªÕ»Ä¡A¤£§Q©ó®ø¤Æ§l¦¬¡C¦h¤¸¤£¹¡©M¯×ªÕ»Ä¨Ì¬Û¾FÂùÁ䪺¦ì¸m¥i¤À¬°¦@³m¯×ªÕ»Ä¡}Conjugated
fatty acid¡~»P«D¦@³m¯×ªÕ»Ä¡}Non-conjugated fatty
acid¡~¡C¦@³m¯×ªÕ»Ä¬O¬Û¾FÂùÁ䤧¶¡¥u¶¡¹j¤@Ó³æÁä¡A«D¦@³m¯×ªÕ»Ä¬O¬Û¾FÂùÁ䤧¶¡¶¡¹j¨âÓ³æÁä¡C¤ÑµMªº¤£¹¡©M¯×ªÕ»Ä¤j¦h¼Æ¬O«D¦@³m¯×ªÕ»Ä¡C¬Y¨Ç¦@³m¯×ªÕ»Ä¥i¯à¦³¯S®íªº¥Í²z®ÄÀ³¡C
4.
¥Í²z¥²»Ý©Ê¡G¥²»Ý¯×ªÕ»Ä¬O¤HÅ餣¯à¦X¦¨¡A¬O¤HÅé©Ò»Ýn¡A©Î¬O¦X¦¨¶q¤£¨¬ªº¯×ªÕ»Ä¡A¥²¶·¥Ñ¹ª«¤¤¨Ñµ¹¡A·íÄá¨ú¶q¤£¨¬®É«h²£¥Í¯Ê¥F¯gµ¥¯e¯f¡C¥²»Ý¯×ªÕ»Ä¥]¬An6¨t¦C¤§¨È³Âªo»Ä¡]C18:2¡^»Pn3¨t¦C¤§¦¸¨È³Âªo»Ä¡]C18:3¡^¡C«D¥²»Ý¯×ªÕ»Ä«h¬O¤HÅé¥i¥H¦Û¦æ¦X¦¨¡A¤£»Ýn¨Ì¿à¹ª«¨ÑÀ³ªº¯×ªÕ»Ä¡C¦p¡G¨È³Âªo»Ä¡B¦¸¨È³Âªo»Äµ¥¥²»Ý¯×ªÕ»Ä¡A¨ä¥\¯à¬°·L¦åºÞ©M²ÓM½¤¤§«n¦¨¤À¡A¯à§Î¦¨Áx©T¾Jà¡B¦å²MÁx©T¾J¤Î¨ä¥L²üº¸»X¤§¦X¦¨¡]¦p«e¦C¸¢¯À¡^¡A¦³§U©ó¦å²G¤§¾®©T¡C
5. ¯S®í¥\¯à¤§¯×½è¡G¦p¯×³J¥Õ¡]Lipoprotein¡^¬O¯×½è»P³J¥Õ½è¥H«D¦@»ùÁäµ²¦Xªº½Æ¦Xª«¡A©ó¦å¼ß¤¤t³d¹B°e¯×½è¡C¥i¤À¬°VLDL¡]Very
low density lipoprotein¡^¡BLDL¡]Low density lipoprotein¡^¡BHDL ¡]High density
lipoprotein¡^¡CÁC¯×½è¡G§ZÁC¯×¡]Lecithin¡^¡CÁޯ׽è¡G¬°¯«¸gÓi°ò¾J¤§«nª«½è¡A¸£¥Ì¯×Ãþ¡]Cerebroside¡^¤ÎÁޯ׽è¦å¼ß½¤µ²ºc¤§¤@¡C©T¾JÃþ¡GÁx©T¾J¡A¥Ñ¥Ö½§¸g¥Ñ¤é¥ú·Ó®g¯à¦X¦¨ºû¥Í¯ÀD²üº¸»X¡CEPA¬°À¦¨à¸£³¡µo¨|©Ò»Ý¡ADHA¬°²üº¸»X¡]¦p«e¦C¸¢¯À¡^¦X¦¨¤§«eÁͪ«¡C
6. ±`¥Îªo¯×¤§¤ÀÃþ¡G«öì®Æ¦Ó¤À¡G°Êª«©Ê¯×ªÕ¡G½Þªo¡AÂûªo¡B¥¤ªo¡A³½ªo
´Óª«©Ê¯×ªÕ¡G¦UºØ¨F©Ôªo¦p¶À¨§ªo¡A¥É¦Ìªo¡A¸ªªáªo¡Aªãªáªo¡Aªá¥Íªo¡A¾ñÆVªo¡A·¦¤lªo¡A´ÄÃqªo¡B³Âªo¡B¦ÌÁRªoµ¥
¤@¯ëì«h¬O°Êª«©Êªo¯×Äݩ󹡩Mªo¯×¡A´Óª«ªo«hÄݩ󤣹¡©Mªo¯×¡C¹¡©Mªo¯×¦b±`·Å¤U¬O©TÅ骺§ÎºA¡A©Ò¥H±`¨£ªº°Êª«ªo¡A¨Ò¦p½Þªo¬O¥Õ¦â©TÅé¡A¥¤ªo¬O¶À¦â©TÅé¡A¦Ó¶À¨§ªo¡BªÛ³Âªo¡Bªá¥Íªoµ¥´Óª«ªo³£¬O²GÅé¡C¦ý¬O¦³¨Ò¥~ªº±¡§Î¡A³½ªoÁöµM¨ú¦Û°Êª«¡A«o¬O¤£¹¡©Mªo¯×¡A±`·Å¬°²GºA¡A¦Ó·¦¤lªo©M´ÄÃqªoÁöµM¨Ó¦Û´Óª«¡A«o¬O¹¡©Mªo¯×¡A±`·Å¬O©TºA¡C
ªo¯×¥[¤u¤¤ªº²B¤Æ§Þ³N¥i¥H§ïÅܪo¯×ªº¹¡©M«×¡A¯×ªÕ»ÄªºÂùÁä¦]¥[²B¦Ó¦¨¬°³æÁä¡AÂǦ¹´î¤ÖÂùÁ䪺¼Æ¥Ø¡A¨Ï¹¡©M«×¼W°ª¡A¦Ó´£ª@ªo¯×ªºÃ©w©Ê¡C²M»ªo¬°½Þªo¥[¤u¦Ó¦¨¡A«Ç·Å¤U¬°²GºA¡A§NÂëh·|¾®µ²¦¨©TºA¡C
²Ä¤T¸` ¯×½è¤§®ø¤Æ¡B§l¦¬»P¥NÁÂ
[top]
1. ®ø¤Æ
¤fµÄ¡G¹ª«¤¤ªºªo¯×§Î¦¨¯×ªÕ²y¡A¯×¸Ñ»Ã¯À¶}©l¶i¦æ¤À¸Ñ§@¥Î¡C®ø¤Æ¤À¸Ñ¯×ªÕªº»Ã¯À¦bÀ¦¨à´Á¦³¦Þ¯×¸Ñ»Ã¯À¡]Lingual
lipase¡^¡AÀHµÛ³è²Gªº¤Àªc»P¹ª«¶i¨ìG¤¤¡C
G¡G±N¤T»Ä¥Ìªoà¨âºÝªº¯×ªÕ»Ä¤ô¸Ñ¤ÀÂ÷¡A¦bG¤¤¤À¸Ñ¯×ªÕ¡Aº¥ý§@¥Î©ó¨âºÝ¯×ªÕ»Äªº¤ô¸Ñ¡A¥Í¦¨¡uÂù»Ä¥Ìªoà¡v¡C»P¯×ªÕ»Ä¡A¤j¬ù¦³30%ªº¤T»Ä¥Ìªoà¥Í¦¨¦¹Ãþ²£ª«¡C¦¨¤H¥Dn¬O§Q¥Î¯ØÅ¦¤Àªcªº¯×¸Ñ»Ã¯À¡A°t¦XÁx¥Ä´£¨ÑÁxÆQÀ°§U¡A±N¯×ªÕ¤À¸Ñ¥H¨Ñ§l¦¬¡C
¯×ªÕ¤£·»©ó¤ô¡A»ÝnÂǧUÁxÆQ»P§ZÁC¯×ªº¨Å¤Æ§@¥Î§Î¦¨¯×ªÕ²y¡A§¡¤Ã¤À´²¦b¤ô¬ÛÀô¹Ò¤¤¡A¨Ã¥B¼W¥[»Ã¯À§@¥Îªºªí±¿n¡A¥H§Q¯×¸Ñ»Ã¯À¶i¦æªo¯×ªº®ø¤Æ¤À¸Ñ¡C®ø¤Æ¬O¤@ºØ¤ô¸Ñ¤ÏÀ³¡A¯×¸Ñ»Ã¯À§â¤ô¤À¤l¥[¨ìàÁä¤W¡A¦Ó¨Ï¯×ªÕ»Ä¤À¸ÑÄÀ©ñ¥X¨Ó¡C
§l¦¬¡G¤T»Ä¥Ìªo઺®ø¤Æ²£ª«¦³³æ»Ä¥Ìªoà¡B¥Ìªo»PµuÃì¡B¤¤Ãì¡BªøÃì¯×ªÕ»Ä¡C²£ª«¤¤¤£·»©ó¤ôªºªøÃì¯×ªÕ»Ä»PÁx©T¾Jµ¥»P³æ»Ä¥Ìªoà¡BÁC¯×½è¡BÁxÆQ§@¥Î§Î¦¨·L¯×²É¡A¥HÂX´²ªº¤è¦¡¶i¤J¤p¸z²ÓM¡C
¤p¸z¡G¨xŦ¦X¦¨ÁxÆQ¡A¸g¥ÑÁx¥ÄÄâ±a¨ì¤p¸z¡AÁxÆQªº¨Å¤Æ§@¥Î¨Ï¯×ªÕ²y§Î¦¨¸û¤pªº¯×ªÕ²É¡A¥H§Q»Ã¯Àªº§@¥Î¡C¤p¸z²ÓM¤º¶i¦æ¤@¨t¦Cªº²Õ¦X§@¥Î¡A§â§l¦¬ªº¯×½è©M¦hºØ³J¥Õ½è¤@¦P²Õ¦X¦¨¨ÅÁS·L²É(Chylomicron)¡A¸g²O¤Ú¨t²Î¹B°e¦Ü¤jÅé´`Àô¡A¿é°e¦Ü©PÃä²Õ´»P¨xŦ§Q¥Î¡A¥H´£¨Ñ¯à¶q¡A¦X¦¨¿E¯À¡A©ÎÀx¦s¦b¯×ªÕ²Õ´¡C§l¦¬§@¥Î¤p¸z²ÓM¡GµuÃì»P¤¤Ãì¯×ªÕ»Ä¡A¥H¤Î¥Ìªoª½±µ³q¹L¤p¸z²ÓM½¤¡A¶i¤J·L¦åºÞ¡A¸g¥Ñ¨xªùÀR¯ß¹B°e¨ì¨xŦ¡C
2. §l¦¬
¯Ø²G¤¤ªº¯×¸Ñ»Ã¯À±N¤T»Ä¥Ìªoà¨âºÝªº¯×ªÕ»Ä§¹¥þ¤ô¸Ñ¡A®ø¤Æ²£ª«¬O¡u³æ»Ä¥Ìªoà¡v¡B¥Ìªo¡BµuÃì¡B¤¤Ãì»PªøÃì¯×ªÕ»Ä¡C
ªøÃì¯×ªÕ»Ä¡B³æ»Ä¥Ìªoà¡BÁx©T¾J¡BÁC¯×½è»PÁxÆQ§@¥Î§Î¦¨·L¯×²É¡C·L¯×²É¥HÂX´²§@¥Î³q¹L¤p¸z²ÓM½¤¡A±Nªo¯×®ø¤Æ²£ª«°e¤J²ÓM¡C¦b²ÓM¤º¡AªøÃì¯×ªÕ»Ä»P³æ»Ä¥Ìªo൲¦X¡A¥Í¦¨¤T»Ä¥Ìªoà¡CªøÃì¯×ªÕ»Ä»P»Ýn¤@ºØ»PAcyl
coA§Î¦¨à¤ÆªºÓi°ò»Ä¡]Carnitine¡^°e¤J²ÓM¤º¤§²É½uÅé¶i¦æ£]®ñ¤Æ¤À¸Ñ¡C¤T»Ä¥Ìªoà¡BÁC¯×½è¡BÁx©T¾Jµ¥»P³J¥Õ½è¤@¦P²Õ¦X¦¨¨ÅÁS·L²É¡A¶i¤J²O¤ÚºÞ¹B°e¡A©óÀV³¡ªþªñ°e¤J¦å²G´`Àô¡C
ªo¯×®ø¤Æ«á¡A¤ô·»©Ê²£ª«¥Ñ·L¦åºÞ¹B°e¡Cªo·»©Ê²£ª«¥Ñ¨ÅÁSºÞ»PªL¤Ú¨t²Î¹B°e¡C
3. ¹B°e
ªo¯×¤£¯à·»¸Ñ¦b¤ô·»²G¤¤¡A¦]¦¹¦b¦å¼ß¤¤±Ä¥Î¯S§Oªº¹B°e§Î¦¡¡AºÙ¬°¯×³J¥Õ¡]Lipoproteins¡^¡A³o¬O¥Ñ¯×½è»P³J¥Õ½è©Òºc¦¨ªº¡A§t¯×½è¶V¦h«h¤ñ«¶V»´¡A¯×½è¥]§t¤T»Ä¥Ìªoà¡AÁx©T¾J©MÁC¯×½è¡C
4. ¥NÁ§Q¥Î¡G
¡]1¡^²Õ´¥NÁ§Q¥Î¡G¨Ó¦Û¹ª«ªº¯×ªÕ§l¦¬«á§Î¦¨¨ÅíÝ·L²É¡A¦b¦åºÞ¤¤¹B°e¦Ü¦U²Õ´¡C¨xŦ¥Í¦¨VLDL¡A±N¯×ªÕ´£¨Ñµ¹¨ä¥L²Õ´¡A¨xŦ·s¥ÍªºHDL¨ã¦³¦¬¶°Áx©T¾Jªº¯à¤O¡C¯×³J¥Õ¦b¦åºÞ¤¤´`Àô¹Lµ{¡A¨ä¯×½è³vº¥¥NÁ¦ÓÅܤơA¦åºÞ¤º¾À¤W§t¦³»Ã¯À¯×³J¥Õ¯×¸Ñ»Ã¯À¡]Lipoprotein
lipase¡^¡At³d¤ô¸Ñ¯×³J¥Õ¤¤ªº¥Ìªoà¥H¨Ñ²ÓM§Q¥Î¡C¯×ªÕ²ÓM§t¦³¯×³J¥Õ¯×¸Ñ»Ã¯À¡A¥i¤À¸ÑÀx¦sªo¯×¡AÄÀ¥X¯×ªÕ»Ä¨Ñ¨ä¥L²Õ´§Q¥Î¡C
¡]2¡^²ÓM¤ºªº§Q¥Î¡G¯×ªÕ»Ä¥i¥H®ñ¤Æ¥Í¦¨ATP¡A¨ÑÀ³¥Í©R©Ò»Ýªº¯à¶q¡A¯×ªÕ²ÓM©Î¨xŦ¥i¥H±N¯×ªÕ»ÄÂন¤T»Ä¥ÌªoàÀx¦s¡A¯×ªÕ»Ä¥i¥H¥Ñ³æÁÞ»P®ò°ò»Ä¥NÁ¦X¦¨¡C
5. ±Æªn¡G
¡]1¡^®ø¤Æ§l¦¬¤£¨}®É¡AÁT«K¤¤§t¦³¤j¶q¯×ªÕ¡A¦¹¯gª¬ºÙ¬°¯×µg¡A
¡]2¡^Áx©T¾J¦b¨xŦ¦X¦¨Áx»Ä©ÎÁxÆQ¡AÀHµÛÁx¥Ä¬y¤J¤p¸z¡A¦pªG»P¿¯¹ÅÖºû©Î¨ä¥Lª«½èµ²¦X¡A¤p¸zµLªk§l¦¬¡A¹F¨ì°§C¦åÁx©T¾Jªº®ÄÀ³¡A§¿²G¤¤³q±`¨S¦³¯×ªÕªº±Æ¥X¡C
6.¤HÅ骺¯×ªÕ²Õ´¡G
¤HÅ餤¶J¦s¦³¨âÃþ¯×ªÕ²Õ´
¡]1¡^¥Õ¦â¯×ªÕ²Õ´¡G¯×ªÕ²ÓM¤¤¤ß¬°³æÓ¯×ªÕ²y¡A²ÓM®Ö©M²ÓM½è³£³QÀ£À½¨ìÃä½t¡A¥Dnªº¥\¯à¬OÀx¦s¯×ªÕ¡C
¡]2¡^´Ä¦â¯×ªÕ²Õ´¡G²Õ´§t¦³¤j¶q·L¦åºÞ¡AÃC¦â¸û¬°²`·t¡A¨ä¯×ªÕ²ÓM§t¦³¼ÆÓ¤j¤p¤£¤@ªº¯×ªÕ²y¡A²É½uÅ鼯¥Ø¯S§O¦h¡A¥Dnªº¥\¯à¬O²£¼ö¥Hºû«ùÅé·Å¡A¹ïÅ髤]¦³¼vÅT¡A¯Ê¤Ö´Ä¦â¯×ªÕ²Õ´ªº°Êª«¦³ªÎDªº²{¶H¡C
²Ä¥|¸` ¯×½èªº»Ýn¶q
[top]
¤@¡Bªo¯×¤§Äá¨úì«h¡G
1. ¨C¤éªo¯×Äá¨ú¶q¤£¶W¹LÁ`¼ö¶qªº30%¡C¦pªG¤@¤Ñ»Ýn¼ö¶q1800¤j¥d¡A«hªo¯×¤§Äá¨ú¶q¤£À³¶W¹L60¤½§J¡C
2. ¹¡©M¯×ªÕªºÄá¨ú¶q¨C¤Ñ¤£¶W¹LÁ`¼ö¶qªº10%¡C
3.
¥²»Ý¯×ªÕ»Ä¤§»Ýn¶q¤£§C©óÁ`¼ö¶qªº2-3¢H¡C¦p¡Gn6¯×ªÕ»Ä¡A¬°¤Fº¡¨¬¨Åé©Ò»Ýªº¥²»Ý¯×ªÕ»Ä¡A¨È³Âªo»ÄC18:2À³¦ûÁ`¼ö¶qªº2%¡A°²³]¨C¤Ñ¼ö¶qÄá¨ú1800¤j¥d¡A«hÀ³§t¦³36¤j¥d¡A¬Û·í©ó4¤½§J¡A§Y2¤p°Í¡]¯ù°Í¡^¨F©Ôªo¡Cn3¯×ªÕ»Ä¡G¦¸¨È³Âªo»ÄC18:3¤]¬O¥²»Ý¯×ªÕ»Ä¡A¨C¤Ñ¤j¬ù»Ýn3¤½§J¡A¦ý¬O¤@¯ëªo¯×¤¤ªº§t¶q¨Ã¤£°ª¡A°£¤F¬Y¨Ç´Óª«ªo¥i¥H¨ÑÀ³¤§¥~¡A¨C¶g¦Ü¤ÖÄá¨ú¨â¦¸°ª¯×®ü³½¡A¨Ò¦pÂD³½©ÎÂC³½¡C¦h¤¸¤£¹¡©M¯×ªÕ»Ä¬ù¦û¼ö¶q3-7%¡C
4. Áx©T¾J¨C¤Ñ¤£¶W¹L300²@§J¡C
¤G¡B¬ü°ê2000¦~¤ßŦ¾Ç·|±Ä¥Î°·±dªº¶¼¹«¬ºA¡G
1. Äá¨ú¦h¼Ëªº½µæ¡B¤ôªG¡A¨C¤Ñ 5 ¥÷¥H¤W
2. Äá¨ú¦h¼Ëªº¤âBÃþ»P¥þâBÃþ¹«~¡A¨C¤Ñ 6 ¥÷¥H¤W
3. ±Ä¥Îªo¯×¶q§C¤§¨Å«~¡B³½¡B¨§Ãþ¡BÂû¦×¡B½G¦×µ¥
4. ªo¯×Ãþ¿ï¥Î¹¡©Mªo¯×§Cªº²£«~¡A¨Ò¦p¡G²GºAªo¡Bªãªáªo¡B¾ñÆVªo
5. ¼ö¶qÄá¨ú°t¦X¨C¤Ñªº¼ö¶q®ø¯Ó¡AÁ×§K¼ö¶q°ª¦ýÀç¾i»ùȧCªº¹ª«
6. ºû«ù°·±d©Ò»Ýªº¤é±`¬¡°Ê¡AÄá¨ú¥¿Å¶¼¹¡A¨C¤ÑÀ³¨B¦æ©Î¨ä¥L¬¡°Ê30¤ÀÄÁ
7. Á×§K¼ö¶q°ª©ÎÀç¾i»ùȧCªº¹ª«¡A¨Ò¦p§t¿}ªº¶¼®Æ»P¿}ªG²¢ÂI
8. Á×§K¹¡©M¯×ªÕ»PÁx©T¾J©Î¤Ï¦¡¯×ªÕ»Ä°ªªº¹ª«¡A¨Ò¦p¡G¥þ¯×¥¤¡BªÎ¦×¡B§t²B¤Æªo¤§¯MµH©Îªo¬µ¹«~¡B¼ö±aªo¯×¡B³J¶Àµ¥
9. ¹ÆQÄá¨ú¶q¨C¤Ñ¤£¶W¹L6¤½§J¡]¶u2400²@§J¡^¬°©y
10. ¨C¤ÑÄá¨ú°sºë¶q¡G¤k©Ê15²@¤É¡A¨k©Ê30²@¤É¡F15²@¤É°sºë¬Û·í©ó¤@¤pªM¯P°s¡A©Î¤@°sªM¬õ°s¡A©Î¤@Åø°à°s¡C
·í¤HÅé¹ï¯à¶qªº»Ý¨D«Ü¤j®É¡A§tªo¯×¦hªº¶¼¹´N«Ü«n¡Q¨Ò¦pÀ¦¨àªº¦¨ªø§Ö³t¡A¤@¦~¤§¤ºÅ髼W¥[¤T¿¡A¦ý¬OG®e¶q«Ü¤p¡A©Ò¥H¥À¨Å©MÀ¦¨à¥¤¯»¤¤ªo¯×¨ÑÀ³ªº¼ö¶q°ª¹F55%¡A°ª©ó¦¨¤Hªº30%«ØÄ³¶q¡QÀ¦¨à¤£¥i¶¼¥Î²æ¯×©Î§C¯×¤û¥¤¡A¤]¤£¾A¦X¶¼¥Î·Ò¨Å¡A³o¨Ç³£·|³y¦¨Àç¾i¯Ê¥Fªº°ÝÃD¡C
ºû«ù°·±d¦X©yªºÅé«¡G
1. ¼ö¶qÄá¨ú°t¦X¨C¤Ñªº¼ö¶q®ø¯Ó¡AÁ×§K¼ö¶q°ª¦ýÀç¾i»ùȧCªº¹ª«
2. ºû«ù°·±d©Ò»Ýªº¤é±`¬¡°Ê¡A¥H¥¿Å¯à¶qªºÄá¨ú
3. ´î«®É¼ö¶q®ø¯Ó¤@©wn¶W¹LÄá¨ú¶q
±±¨î¦å¯×»PÁx©T¾J¡G
1. ¹ï¹¡©M¯×ªÕ»Ä»PÁx©T¾J¡A©Î¤Ï¦¡¯×ªÕ»Ä°ªªº¹ª«À³¸`¨î¹¥Î
2. ªo¯×¨Ó·½ºÉ¶q§Q¥Î¤âBÃþ¡B½µæ¡B³½¡B¨§¡B°íªGÃþ´£¨Ñ¤§¤£¹¡©Mªo¯×
ºû«ù°·±d¦åÀ£¡G
3. ¹ÆQÄá¨ú¶q¨C¤Ñ¤£¶W¹L6¤½§J¬°©y
4. ¸`¨î°sºëÄá¨ú
¤T¡B°ê¤H¤§ªo¯×Äá¨úª¬ªp
¨Ì¾Ú¥xÆW¾ú¦~°ê¥ÁÀç¾i½Õ¬dµ²ªG¡A¦¨¤H¨k¤l¨C¤H¨C¤é¤§¥§¡Äá¨ú¶q½d³ò¬O81-90¤½§J¡A¦ûÁ`¼ö¶qªº¤ñ¨Ò¬°31.7%-36%¡C¦Û¥Á°ê75¦~¥H¨Ó°ê¤Hªo¯×Äá¨ú¶q¶W¹L½Ã¥Í¸p«ØÄ³¤§30%¡C¦Ó³Ìªñªº°ê¥ÁÀç¾i°·±dª¬ªpÅܾE½Õ¬dµ²ªG¡A19-64·³¨k©Ê¨C¤H¥§¡ªº¯×ªÕÄá¨ú¶q¬ù¬°¨C¤Ñ79.5¤½§J¡A¦ûÁ`¼ö¶q¤§33.5%¡F19-64·³¤k©Ê¨C¤H¥§¡ªº¯×ªÕÄá¨ú¶q¬ù¬°¨C¤Ñ61.1¤½§J¡A¦ûÁ`¼ö¶q¤§34.4%¡C
°ê¤H¶¼¹¤§¯×ªÕ»Ä¤À°t¤ñ¨Ò¬°¥H¹¡©M¡}S¡~¡G³æ¤£¹¡©M(M)¡G¦h¤£¹¡©M(P)
ªí¥Ü¡A¨k©Ê¤j¬ù¬O0.85/1.17/1¡A¤k©Ê¬O0.95/1.15/1¡FP/S¤ñ¨Ò±µªñ©ó1¡A¤ñ¼Ú¬ü°ê®a¬°Àu¡C¨C¤H¨C¤éªºÁx©T¾JÄá¨ú¶q¥§¡¬°¨k©Ê344²@§J¡A¤k©Ê264²@§J¡C¨ÑÀ³ªo¯×ªº¥Dn¹ª«¨Ó·½¡A²Ä¤@¦ì¬O®a¯bÃþ¤Î¨ä»s«~¡A¯S§O¬O½Þ¦×¤Î¨ä¥[¤u«~¡A¨ä¦¸¬Oªo¯×Ãþ¡A¥H´Óª«ªoÃþ¬°¥D¡CÁx©T¾Jªº¥Dn¹ª«¨Ó·½¬O·sÂA³JÃþ¡A¦×¤Î¦×¥[¤u«~¡C
¥|¡B±±¨î¶¼¹¯×ªÕ¶qªº¤èªk
¥Ñ©ó¤ß¦åºÞ¯e¯fªº¦MÀI¦]¤l¤¤¡A¿}§¿¯f¡A°ª¦åÀ£¡A°ª¦å¯×©MªÎD¬O»P¶¼¹ª½±µ¦³Ãöªº¡A¥i¥H¹B¥ÎÀç¾iª¾ÃÑ¥[¥H±±¨î©Î½Õ¾ã¶¼¹¡CÁöµM¡A¦åºÞ¤¤³£©Î¦h©Î¤Ö¦³¯×ªÕªº°ï¿n¡A¦ý¬O¡A¨}¦nªº¥Í¬¡¤Î¶¼¹²ßºD¦³§U©ó´î½w°ï¿nªº³t«×¡C
¤¡B¹ª«¿ï¥Îì«h¡G
¿ï¥Î¯×ªÕ§t¶q§CªÌ¡A¦p¡G¥ÍÂAÃþ¤½\®Ú²ôÃþ¡A²æ¯×¥¤¡B§C¯×¥¤¡B§C¯×Àu¹T¨Å¡B§C¯×°_¥q¨Å¹Tµ¥¥¤Ãþ¡B¨Å»s«~¡CÂû¦×¡B¥þ½Gªº½Þ¡B¤û¦×¨Ì¶·n¿ï¥Î¡A½µæ¤ôªGÃþ¬Ò¥iÀH·N¿ï¥Î¡A¨C¶g¤T¦¸¥H¤W¡An-3¯×ªÕ»Ä³½¨©®üÂA¡C¤Ö¥Î°ª¯×ªÕªº²£«~¡A¦p¡Gªo¶º¡B°ªªoÄÑ¥]¥þ¯×¥¤¡B¦B²N²O¡B°_¥q¨Å¹T¡B¤T¼h¦×¡B¤ªá¦×¡B»¸zþ¦×µ¥¡C
¤»¡B§C¯×²i½Õn»â¡G
1. ¥h°£¦×Ãþ¥i¨£ªº¯×ªÕ¡AÂûÀn¥h¥Ö
2. ¬õ¿N¦×Ãþ©Î¿LµN¦×´ö«á¡A¥i¥ý¦s©ñ¦b¦B½c¤º¡A¹j¤é¥h±¼¯B°_¾®µ²ªºªo«á¦A¥[¼ö¹¥Î
3. ¥Î²M»]¡B¤t¿S¡B¬õ¿N¡B·Lªi¡B¯M¯N¥N´Àªoª£©Îªo¬µªº²i½Õ
4. ±Ä¥Î´î¤Ö¥Îªo¶qª£µæ¡A±Ä¥Î»®Æ¡B¾L¡B½µ¡B»[µ¥¼W¥[·¨ý¡A¨Ï¥Î¶q°Í±±¨î²K¥[ªºªo¶q¡Aµ½¥ÎÁç¨ã´î¤Ö¥Îªo¶q¡C
²Ä¤¸` ¯×½è»P¤ß¦åºÞ¯e¯f¯×½è¤§¯Ê¥F¯g
[top]
¤ß¦åºÞ¯e¯f¬O¤ßŦ¯f»P¦åºÞ¯e¯fªºÁ`ºÙ¡C«aª¬°Ê¯ß¬O¨ÑÀ³¤ßŦ®ñ®ð»P¾i¤Àªº¦åºÞ¡A·í¨ÑÀ³¤ßŦªº¦å²G´î¤Ö¦Ó¹ï¤ßŦ³y¦¨¶Ë®`§Î¦¨¤ßŦ«aª¬°Ê¯ß¯e¯f(Coronary
heart
disease)¡A°Ê¯ßµ°ª¬µw¤Æ(Atherosclerosis)»P°ª¦åÀ£¬O±`¨£ªº¯e¯f¡Cµ°ª¬µw¤Æ¬O«ü°Ê¯ßºÞ¾À¤W¥Í¦¨¸~¶ô¡A¥Ñ¥·Æ¦Ù²ÓM¡BÅÖºû³J¥Õ½è¡B¯×ªÕ¡B²ÓM´Ý´íºc¦¨¡A¨Ã¦³µ{«×¤£¤@ªº¥X¦å¡BÃa¦º¡B¶t¤Æªº²{¶H¡Aµ°ª¬µw¶ô¥~³ò±`ªþ¦³¦å®ê¡C
¦åºÞ¾À¦]¦¹µw¤Æ²ÊÁW¤£¥¡BºÞ®|Åܤp¡A¦å¬yªý¤O¼W¤j¡B¦å¬y¶q´î¤Ö¡B²Õ´Àò®ñ»P¾i¤À¨ÑÀ³´î¤Ö¡C¦åºÞ¾À©Ó¨üÀ£¤O¤j¡A®e©ö¨ü¶Ë¡A¦Ó©ö¥Í¦¨¦å®ê¡A¨Ïªý¶ëªº±¡ªp§ó¬°´c¤Æ¡C³Ì«á²£¥Í½ÆÂø¦Ó¤£¥i°fªº¦åºÞ¾Àµ°ª¬¶ô¡C
°Ê¯ßµw¤Æ°_¦]©ó¦å¤¤LDL®ñ¤Æ©Ò¤Þ°_ªº¦åºÞ¾À¯fÅÜ©Mµoª¢¤ÏÀ³¡A¯f¯g¦³¶¥¬q©ÊªºÅܤơCº¥ý¡A¦å¤¤¹L¶qªºLDL»E¶°¦b°Ê¯ß¤º¾À¤W¨Ã¥Bµo¥Í®ñ¤Æ¡A¨ë¿E¤º¥Ö²ÓM¤ÀªcÂH©Ê¤À¤l¡A§l¤ÞT²ÓM©M³æ®Ö²y²ÓMÂHªg¨Ã«I¤J¦åºÞ¤º½¤¡C¦b¦åºÞ¤º½¤¡A³æ®Ö²y¬¡¤Æ¦¨¬°¥¨¾½²ÓM¡A²£¥Í³\¦hµoª¢ª«½è¡A¨Ã¥B§]¾½¤j¶qªº®ñ¤ÆLDL¡A§Î¦¨¯×ªÕ°ï¿nªºªw²ÓM¡]foam
cells¡^»P¯×ªÕ¶ô¡A³o¬Oµ°¸~ªºªì´Á¡A¦¹¶¥¬q¬°¥i°f©Ê¡A¦pªG§´µ½¹w¨¾¥i¥H°fÂà¶Ë®`©ÊªºÅܤơC
¸~¶ô¥H¯×ªÕ¬°¤¤¤ß³vº¥¼W¤j¡A³Q¶gÃ䪺¦Ù¦×²ÓM¥]³ò¡A¦Ù¦×²ÓM§Î¦¨ÅÖºûª¬µw´ß¡A¹jÂ÷¸~¶ô»P¦å¬y¡Cªw²ÓM¤Àªc¦hºØµoª¢ª«½è¡A¯}Ãa©P³òªº¦Ù¦×²ÓM»PÅÖºûª¬µw´ß¡A¾ÉP¸~¶ô¯}µõ¦ÓµLªk×´_¡A·l¶ËªººÞ¾À²Õ´ÄÀ¥Xªº¦¨¤À·|«P¶i¦å¤pªO¾®¶°¡A§Î¦¨¾®¦å¶ô©Î¦å®ê¡A¦å®ê©Î¦å¶ô¹L¤j´N·|ªý¶ë¦å¬y¡Aµo¥Í©ó¸£¦åºÞ«h¬O¤¤·¡Fµo¥Í©ó¤ßŦ¦åºÞ«h¬O¤ß¦Ù±ð¶ëªºì¦]¤§¤@¡A¤ß¦Ù¦]¯Ê®ñ¦ÓÃa¦º¡C
¤@¡B¤ß¦åºÞ¯e¯fªº¦MÀI¦]¤l¡G
¥Dn¦MÀI¦]¤l
1. ¿ò¶Ç(®a±Ú¯f¾ú) ¡G¦µo©ÊCAD¡]½T©w¬°¤ß¦Ù±ð¶ë¡B¤÷¿Ë©Î¨k©Ê¤@µ¥¿Ë¦b55·³¥H«eÖ`¦º¡B¥À¿Ë©Î¤k©Ê¤@µ¥¿Ë¦b65·³¥H«eÖ`¦º¡^¡C
2. ©Ê§O¡G¨k©Êªº¦MÀI°ª©ó¤k©Ê
3. ¦~ÄÖ¡G¨k©Ê¡Ù45¡A¤k©Ê¡Ù55¡A©Î¹L¦°±¸g¦ÓµL¤k©Ê²üº¸»XªvÀø
¥i¹w¨¾¤§¦MÀI¦]¤l
4. ¸g±`©Ê©â·Ï
5. °ª¦åÀ£¡G¦åÀ£¡Ù140/90 mmHg©ÎªA¥Î°ª¦åÀ£ÃĪ«
6. ¦å¯×²§±`¡G¦å¯×¤§¤À¯Å¼Ð·Ç¦p¤U¡AÁ`Áx©T¾J²z·QÈ< 200¡A°¾°ª200~239²§±`°¾°ª¡Ù240¤T»Ä¥Ìªoà²z·QÈ<
150°¾°ª150~199²§±`°¾°ª200~499ÄY«¹L°ª¡Ù500¡FLDL Áx©T¾J²z·QÈ< 100²¤°ª100~129°¾°ª130~159²§±`°¾°ª160~189ÄY«¹L°ª¡Ù190 HDL Áx©T¾J°¾§C< 40²z·Q¡Ù60
¤G¡B°§C¤ß¦åºÞ¯e¯fªºµ¦²¤¡G
1. ¶¼¹½Õ¾ã¡G¥H°§CLDL»P¤É°ªHDL¬°¥Ø¼Ð¡GÁ×§K¼ö¶q¹L³Ñ¡A¸`¨îªo¯×ªºÁ`Äá¨ú¶q¡A¿ï¥Î³æ¤¸¤£¹¡©Mªo¯×¡A±±¨î¹¡©M¯×ªÕ¡Ø7%¼ö¶q¡A¦h¤¸¤£¹¡©M¯×ªÕ»Ä¥i°§CLDL¡A¦ýµLªk¼W¥[HDL¡CÁx©T¾J¨C¤Ñ¡Ø200
mg¡AÄá¨ú¨¬¶q¤ô·»©Ê¿¯¹ÅÖºû¡A¿ï¥Î½µæ¡B¤ôªG¡B¨§Ãþ¡B¤½\Ãþ¡A§Q¥Î½µæ¡B¤ôªG¡B¨§Ãþ´£¨Ñ§Ü®ñ¤Æ¦¨¤À»PB¸sºû¥Í¯À¡C
2. ¥Í¬¡«¬ºA¡Gºû«ù²z·QÅé«¡AÁ×§KÅ髤W¤É¡A§ÙµÒ¡A¨C¤ÑÀ³¸Ó¦³30¤ÀÄÁªº¬¡°Ê¡AÁ×§KÀRºA¥Í¬¡¡C
3. ±±¨î¦åÁx©T¾J¡G20·³¥H¤W¦¨¤HÀ³¨C5 ¦~´ú¶q¦åÁx©T¾J»P¦å¯×ÃЫ¬¡A¥H¤F¸Ñ¦å¯×ªº¾ãÅ骬ªp¡A¥]¬AÁx©T¾J¡B¤T»Ä¥Ìªoà¡BLDL¡BHDLµ¥¡C
4.
¼W¥[¦³¯q¤ßŦ¦åºÞ«O°·ªº¶¼¹¦¨¤À¡G§Ü®ñ¤Æ¦¨¤À¡Gºû¥Í¯ÀE»P¦UºØ´Óª«¥\®Ä¦¨¤À¡A§í¨î¦å¤¤¯×½èªº®ñ¤Æ¡BB¸sºû¥Í¯À¡G¸»Ä¡BB6¡BB12¥R¨¬¡A°§C¦å¤¤¦P¥b¥úÓi»Ä¿@«×¡A°§C¦åºÞ·l¶Ë¡Bn3¯×ªÕ»Ä¡G´î¤Ö¦å®ê¥Í¦¨¡A¥i¯à§í¨îµoª¢¤ÏÀ³¡B¿¯¹ÅÖºû¡G¼W¥[ÁxÆQ±Æªn¡A°§C¦åÁx©T¾J¡B¶À¨§³J¥Õ½è¡G¨C¤ÑÄá¨ú25¤½§J¦³§U©ó°§C¦åÁx©T¾J¡C
ÀHµÛ°ê¤H¤ß¦åºÞ¯e¯fµ¥¤å©ú¯f¿©±w²vªº¤W¤É¡A¤ßŦ¯e¯f¦MÀI©Êªºµû¦ô¥u¯à¥Ñ¤@¨Ç¦MÀI¦]¤l±À´ú¨äµo¥Í²v¡C»P¤ßŦ¦åºÞ¯e¯f¦³¥¿¬ÛÃö©Êªº¦MÀI¦]¤l¬O¡G¿ò¶Ç¡B©Ê§O¡B¦~ÄÖ¡B©â·Ï¡B¿}§¿¯f¡B°ª¦åÀ£¡BªÎD¡Bºò±iÀ£¤O¡B¤Î¯Ê¥F¹B°Ê¡C
¤T¡Bªo¯×»PÀù¯g
¨Ì¾Ú¬y¦æ¯f¾ÇÆ[¹î¡G°ê®a¤§¶¡ªº¤ñ¸û¡Aªo¯×Äá¨ú°ªªº°ê®a¡A¨ÅÀù»P¤j¸zÀùªº¦º¤`²v¸û°ª¡C
®Ú¾Ú¦è¤è°ê®aªº¬ã¨s¡A»PÀù¯g¦³Ãöªº¶¼¹¦]¯À¥i¯à¬O¼ö¶q¹L³Ñ¡A¦Ó«D³æ¯Âªºªo¯×Äá¨ú¶q¡C¬ü°êÀù¯gÂå¾Ç·|¡}American Cancer
Society¡~«ØÄ³ªº¨¾Àù¶¼¹»P¥Í¬¡ì«h
¡GÄá¨ú°·±d¦h¼Ëªº¹ª«¡Aµ½¥Î´Óª«©Ê¹«~¡G¨C¤ÑÄá¨ú¤¥÷½µæ©M¤ôªG¡BÀu¥ý¿ï¥Î¥þâBÃþ¹ª«¡Bªo¯×°ª©Î¥[¤uªº¬õ¦×»s«~©y¸`¨îÄá¨ú¡B¤é±`¶¼¹¥Hºû«ù°·±dÅ髬°¥Ø¼Ð¡B°ö¾i¬¡¤O¦n°Êªº¥Í¬¡«¬ºA¡B¦¨¤H¡G¨C¤ÑÀ³¦³¤¤«×¬¡°Ê30¤ÀÄÁ¡A¨C¶g¦Ü¤Ö¹ê¦æ¤¤Ñ¡B¨àµ£»P«C¤Ö¦~¡G¨C¤ÑÀ³¦³¤¤«×¦Ü¼@¯Pªº¬¡°Ê60¤ÀÄÁ¡A¨C¶g¦Ü¤Ö¹ê¦æ¤¤Ñ¡C
¤@¥Íºû«ù°·±dªºÅ髱Ħæ°ÊºAªº¥Í¬¡¨Ó¥¿Å¼ö¶qªºÄá¨ú¡B¹L«©ÎªÎDªÌ©y¶}©l°õ¦æ´î«p¹º¡C¶¼°s°È¥²¸`¨î¥Î¶q¡A¤k©Ê¨C¤Ñ¤@ªM¡A¨k©Ê¨C¤Ñ¨âªM¬°¡C¶¼°s»P¤k©Ê¨ÅÀù¦³±K¤ÁªºÃöÁp¡C
¥|¡B¯×ªÕ¤£¨¬¤§¯Ê¥F¯g¡G
¶¼¹¤¤¯×ªÕÄá¨ú¤£¨¬®É¡A³y¦¨Åé¯×ªÕ¤£¨¬¡A¨Ï±o¨àµ£¥Íªø¿ðº¢¡A¤k©Ê«h·|°±¸g»P¤£¥¥ªº²{¶H¡C
¤pÀɮסGOmega-3¯×ªÕ»Ä
[top]
Omega-3¯×ªÕ»Ä¡G³½ªo¤¤§t¦³«Ü¦h¤§Omega-3¯×ªÕ»Ä¡A¥]¬AEPA¡]Eicosapentaenoic
acid¬°20ÓºÒ§t5ÓÂùÁä¡^¡AEPA¬°À¦¨à¸£³¡µo¨|©Ò»Ý¡BDHA¡]Docosahexanenoic
acid¬°22ÓºÒ§t6ÓÂùÁä¡^¦³§U©ó½Õ¸`¤ß¦åºÞ¥\¯àªºùÚ©w»P¼vÅT¦å²G¤§¾®¶°¡A¤]¬O²üº¸»X¡]¦p«e¦C¸¢¯À¡^¦X¦¨¤§«eÁͪ«¡C§¡»P¤HÅ餧°·±d»P§K¬Ì¬ÛÃö¡C
¤pÀɮסG¤¤Ãì¯×ªÕ»Ä¡]MCT¡^
¤¤Ãì¯×ªÕ»Ä¡]Medium chain triglycerides, MCT¡^§t¦³6-10ÓºÒÃ쪺¯×ªÕ»Ä¡A¶i¤J¸z¹D«á¥u»Ýn20¤ÀÄÁ¡A§Y¥i³Q®ø¤Æ§l¦¬¦Ü²O¤ÚºÞ¦Ü¦å²G¤¤¡A³q±`¥i§@¬°»Ýn¶i¦æºÞÄé¹±wªÌªº¯×ªÕ¨Ó·½¡C
°Ñ¦Ò¤åÄm
[top]
1. ¤ý»ñ^µ¥µÛ¡A¹ê¥ÎÀç¾i¾Ç¡A¥Á°ê88¥Xª© µØÄË¥Xª©ªÀ¡A¥x¥_¥«¡C
2. °ê¤H¿¯¹Àç¾i¯À°Ñ¦ÒÄá¨ú¶q¤Î¨ä»¡©ú×q²Ä¤»ª©¡C¦æ¬F°|½Ã¥Í¸p¡]2003¡^¡C
3. Chanmugam P, Guthrie JF, Cecilio S, Morton JF, Basiotis PP, Anand R.
Did fat intake in the United States really decline between 1989--1991
and 1994--1996? J Am Diet Assoc 2003;103:867--72.
4. Whitaker RC, Wright JA, Finch AJ, Psaty BM. An environmental
intervention to reduce dietary fat in school lunches. Pediatrics
1993;91(6):1107-11.
5. Freedman DS, Burke GL, Harsha DW, et al. Relationship of changes in
obesity to serum lipid and lipoprotein changes in childhood and
adolescence. JAMA 1985;254(4):515-20.
6. Kikuchi DA, Srinivasan SR, Harsha DW, Webber LS, Sellers TA, Berenson
GS. Relation of serum lipoprotein lipids and apolipoproteins to obesity
in children: the Bogalusa Heart Study. Prev Med 1992;21:177-90.
7. Laskarzewski P, Morrison JA, Mellies MJ, et al. Relationships of
measurements of body mass to plasma lipoproteins in schoolchildren and
adults. Am J Epidemiol 1980;111(4):395-406.
8. Resnicow K, Morabia A. The relation between body mass index and
plasma total cholesterol in a multiracial sample of US schoolchildren.
Am J Epidemiol 1990;132(6):1083-90.
9. Shear CL, Freedman DS, Burke GL, Harsha DW, Berenson GS. Body fat
patterning and blood pressure in children and young adults: the Bogalusa
Heart Study. Hypertension 1987;9:236-44.
10. National Heart, Lung, and Blood Institute. Report of the expert
panel on population strategies for blood cholesterol reduction.
Bethesda, MD: US Department of Health and Human Services, Public Health
Service, National Institutes of Health, 1990. NIH publication no.
90-3046.
11. Otvos JD, Shalaurova I, Freedman DS, Rosenson RS. Effects of
pravastatin treatment on lipoprotein subclass profiles and particle size
in the PLAC-I trial. Atherosclerosis 2002;160:41¡V8.
12. Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein
subclass levels and low-density lipoprotein size to progression of
coronary artery disease in the Pravastatin Limitation of Atherosclerosis
in the Coronary Arteries (PLAC-I) Trial. American Journal Cardiology
2002;90:89¡V94.
13. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the
risk of coronary heart disease in women. N Engl J Med.
1997;337:1491-1499.
14. Trichopoulo A, Katsouyanni K, Stuver S, et al. Consumption of olive
oil and specific food groups in relation to breast cancer risk in
Greece. J Natl Cancer Inst. 1995;87:110-116.
15. Decker EA. The role of phenolics, conjugated linoleic acid,
carnosine, and pyrroloquinoline quinone as nonessential dietary
antioxidants. Nutr Rev 1995;53:49-58.
16. Slesinski MJ, Subar AF, Kahle LL. Dietary intake of fat, fiber and
other nutrients is related to the use of vitamin and mineral supplements
in the United States: the 1992 National Health Interview Survey. J Nutr
1996;126:3001-3008.
17. Prentice RL. Future possibilities in the prevention of breast
cancer: fat and fiber and breast cancer research. Breast Cancer Res.
2000;2:268-276.
18. Sigman-Grant M. Can you have your low-fat cake and eat it too? The
role of fat-modified products. J Am Diet Assoc. 1997;97:S76-S81.
19. Auld GW, Nitzke SA, McNulty J, Bock MA, Bruhn CM, Gavel K, Lauritzen
G, Lee YF, Medeiros D, Newman R, Ortiz M, Read M, Schutz H, Sheehan E. A
stage-of-change classification system based on actions and beliefs
regarding dietary fat and fiber. Am J Health Promot. 1998;12(3):192-201.
20. Ribaya-Mercado JD. Influence of dietary fat on beta carotene
absorption and bioconversion into vitamin A. Nutr Rev 2002;60:104-110.
21. Conquer JA, Holub BJ. Supplementation with an algae source of
docosahexaenoic acid increases (n-3) fatty acid status and alters
selected risk factors for heart disease in vegetarian subjects. J Nutr
1996;126:3032-3039.
22. Ågren JJ, Tormala ML, Nenonen MT, Hanninen OO. Fatty acid
composition of erythrocyte, platelet, and serum lipids in strict vegans.
Lipids 1995;30:365-369.
23. Krajcovicova-Kudlackova M, Simoncic R, Babinska K, Bederova A.
Levels of lipid peroxidation and antioxidants in vegetarians. Eur J
Epidemiol 1995;11:207-211.
24. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell
V, Hargrove RL, Zhao G, Etherton TD. Polyunsaturated fatty acids in the
food chain in the United States. Am J Clin Nutr 2000;71:179S-188S.
25. Indu, M and Ghafoorunissa. N-3 fatty acids in Indian diets
Comparison of the effects of precursor (alpha-linolenic acid) vs.
product (long chain n-3 polyunsaturated fatty acids). Nutr Res
1992;12:569-582.
26. Masters C. Omega-3 fatty acids and the peroxisome. Mol Cell Biochem
1996;165:83-93.
27. Pereira C, Li D, Sinclair AJ. The alpha-linolenic acid content of
green vegetables commonly available in Australia. Int J Vitam Nutr Res
2001;71:223-228.
28. Burdge GC, Jones AE, Wooton SA. Eicosapentaenoic and
docosapentaenoic acids are the principal products of alpha-linolenic
acid metabolism in young men. Br J Nutr 2002;88:355-363.
29. Sanders TAB, Reddy S. The influence of a vegetarian diet on the
fatty acid composition of human milk and the essential fatty acid status
of the infant. J Pediatr 1992;120:S71-S77.
30. Hornstra G. Essential fatty acids in mothers and their neonates. Am
J Clin Nutr 2000;71(suppl):1262S-1269S.
31. Sacks FM, Rouse IL, Stampfer MJ, Bishop LM, Lenherr CF, Walther RJ.
Effect of dietary fats and carbohydrate on blood pressure of mildly
hypertensive patients. Hypertension 1987;10:452-460.
ºô¶¡G
1. ¦æ¬F°|°ê®a¬ì¾Ç©eû·|¬ì¾Ç§Þ³N¸ê®Æ¤¤¤ß
HTTP://WWW.STIC.GOV.TW/
2. ¦æ¬F°|½Ã¥Í¸p¡G¹«~¸ê°Tºô¡Chttp://food.doh.gov.tw/nutrition/htm
3. °¨°º¬ö©ÀÂå°|Àç¾i½Ò¥þ²yºô¸ôº¶
HTTP://WWW2.MMH.ORG.TW/NUTRITION/DDMAIN.HTM
4.¥x¥_ºaÁ`Àç¾i³¡
HTTP://WWW.VGHTPE.GOV.TW/~NUTR/
5. http://www.cdc.gov/mmwr/preview/mmwrhtml/00042446.htm
6. http://www.cfsan.fda.gov/~dms/fdfats.html
¡@ |